Synthesised sponge chemical shows promise for cancer

A promising compound for cancer treatment has been synthesised in a laboratory by an RMIT University researcher conducting PhD research.

Dr Dan Balan, from the School of Applied Sciences at RMIT, said 15-aza-Salicylihalamide A analogue had demonstrated potent activity against several leukaemia cell lines.

"Salicylihalamide A is an interesting natural marine product that has been isolated from a marine sponge of the genus Haliclona, collected from waters around Rottnest Island, 18 km off the coast of southern Western Australia," Dr Balan said.

Salicylihalamide A is cytotoxic – or a toxin which is known to destroy cells and which also provides a defence for the sea sponge.

"My goal was to synthesise the chemical in the laboratory in the form of a single aza-salicylihalamide A analogue molecule," he said.

The aza-salicylihalamide A analogue molecules were then exposed to NCI-60 leukaemia cell lines, and exhibited antiproliferating effects on the group of cells at highly diluted, or 'sub-molar,' concentrations.

"15-aza-Salicylihalamide A Analogue has proven to be very active against various types of , but it was clearly most active against HL-60, which is acute promyelocytic leukaemia," he said.

Other findings revealed it to be an inhibitor of vacuolar ATPase and proton pumps, frequently found in metastatic cancer – which are that have migrated through the bloodstream from more advanced tumours.

"The molecule was synthesised in a short molecular sequence that could be easily produced in very large volumes for drug production," Dr Balan said.

He explained there will be further research to investigate its effectiveness on different cancers, potentially leading to extensive drug development.

add to favorites email to friend print save as pdf

Related Stories

Power lines don't raise risk of leukaemia in children

Feb 07, 2014

(Medical Xpress)—Children who live near overhead power lines in early life do not have a greater risk of developing childhood leukaemia, researchers from the Childhood Cancer Research Group at the University ...

Small molecule shows promise as anti-cancer therapy

Jan 13, 2014

Johns Hopkins scientists say a previously known but little studied chemical compound targets and shuts down a common cancer process. In studies of laboratory-grown human tumor cell lines, the drug disrupted tumor cell division ...

Recommended for you

US women's awareness of breast density varies

12 hours ago

Disparities in the level of awareness and knowledge of breast density exist among U.S. women, according to the results of a Mayo Clinic study published in the Journal of Clinical Oncology.

Study shows why some brain cancers resist treatment

12 hours ago

Scientists at The University of Texas MD Anderson Cancer Center may have discovered why some brain cancer patients develop resistance to standard treatments including radiation and the chemotherapy agent temozolomide.

Researchers identify genes responsible for lung tumors

14 hours ago

The lung transcription factor Nkx2-1 is an important gene regulating lung formation and normal respiratory functions after birth. Alterations in the expression of this transcription factor can lead to diseases such as lung ...

User comments

Please sign in to add a comment. Registration is free, and takes less than a minute. Read more

Click here to reset your password.
Sign in to get notified via email when new comments are made.